Systematic review and meta‐analysis of left ventricular endocardial pacing in advanced heart failure: Clinically efficacious but at what cost?

Abstract: Introduction: Cardiac resynchronization using a left ventricular (LV) epicardial lead placed in the coronary sinus is now routinely used in the management of heart failure patients. LV endocardial pacing is an alternative when this is not feasible, with outcomes data sparse. Objective: To...

Descripción completa

Detalles Bibliográficos
Publicado en:Pacing & Clinical Electrophysiology Vol. 41; no. 4; pp. 353 - 362
Autores principales: Graham, Adam J., Providenica, Rui, Honarbakhsh, Shohreh, Srinivasan, Neil, Sawhney, Vinit, Hunter, Ross, Lambiase, Pier
Formato: meta analysis research systematic review tables/charts Journal Article
Publicado: Wiley-Blackwell Apr2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=129103148&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 129103148
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01478389
        4F8
      jtl: Pacing & Clinical Electrophysiology
      issn: 01478389
      maglogo: Y
    pubinfo:
      dt: Apr2018
      vid: 41
      iid: 4
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        129103148
        129103148
        129103148
        10.1111/pace.13275
        129103148
      ppf: 353
      ppct: 9
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Systematic review and meta‐analysis of left ventricular endocardial pacing in advanced heart failure: Clinically efficacious but at what cost?
      aug:
        au:
          Graham, Adam J.
          Providenica, Rui
          Honarbakhsh, Shohreh
          Srinivasan, Neil
          Sawhney, Vinit
          Hunter, Ross
          Lambiase, Pier
        affil: Clinical Research Fellow, Barts Heart Centre, West Smithfield, London, EC1A 7BE, UK
      sug:
        subj:
          Heart Failure Therapy
          Cardiac Pacing, Artificial Methods
          Heart Ventricle, Left
          Treatment Outcomes
          Cardiac Pacing, Artificial Adverse Effects
          Human
          Systematic Review
          Meta Analysis
          Cardiac Resynchronization Therapy
          Coronary Vessels
          Medline
          Embase
          Cochrane Library
          Ventricular Ejection Fraction
          QRS Complex
          Descriptive Statistics
          Confidence Intervals
          P-Value
          Mortality
          Heart Failure Classification
          Stroke Diagnosis
          Electrodes
          Stroke Risk Factors
      ab: Abstract: Introduction: Cardiac resynchronization using a left ventricular (LV) epicardial lead placed in the coronary sinus is now routinely used in the management of heart failure patients. LV endocardial pacing is an alternative when this is not feasible, with outcomes data sparse. Objective: To review the available evidence on the efficacy and safety of endocardial LV pacing via meta‐analysis. Methods: EMBASE, MEDLINE, and COCHRANE databases with the search term “endocardial biventricular pacing” or “endocardial cardiac resynchronization” or “left ventricular endocardial” or “endocardial left ventricular.” Comparisons of pre‐and post‐QRS width, LV ejection fraction (LVEF), and New York Heart Association (NYHA) functional classification was performed, and mean differences (and respective 95% confidence interval [CI]) applied as a measurement of treatment effect. Results: Fifteen studies, including 362 patients, were selected. During a mean follow‐up of 40 ± 24.5 months, death occurred in 72 patients (11 per 100 patient‐years). Significant improvements in LVEF (mean difference 7.9%, 95% CI 5–10%, P < 0.0001; I2 = 73%), QRS width (mean difference: –41% 95% –75 to –7%; P < 0.0001; I2 = 94%), and NYHA class (mean difference: –1.06, 95% CI –1.2 to –0.9, P < 0.0001; I2 = 60%), (all P < 0.0001) occurred. Stroke rate was 3.3–4.2 per 100 patient‐years, which is higher than equivalent heart failure trial populations and recent meta‐analysis that included small case series. Conclusion: LV endocardial lead implantation is a potentially efficacious alternative to CS lead placement, but preliminary data suggest a potentially higher risk of stroke during follow‐up when compared to the expected incidence of stroke in similar cohorts of patients.
      pubtype: Academic Journal
      doctype:
        meta analysis
        research
        systematic review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N